| ELI LILLY & CoLLY | Oncology, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive, Psychiatry | 7.7 | $1.05T | Commercial | NYSE |
| JOHNSON & JOHNSONJNJ | Oncology, Neurology, Immunology, Ophthalmology, Cardiovascular, Respiratory, Pain, Dermatology, Gastroenterology, Psychiatry | 4.6 | $645.95B | Commercial | NYSE |
| AbbVie Inc.ABBV | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive, Psychiatry | 8.2 | $451.46B | Commercial | NYSE |
| Merck & Co., Inc.MRK | Oncology, Rare Disease, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Reproductive | 6.7 | $366.00B | Commercial | NYSE |
| Novartis AGNVS | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive, Psychiatry | 9.0 | $292.35B | Commercial | NYSE |
| ASTRAZENECA PLCAZN | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive | 8.1 | $252.33B | Commercial | NYSE |
| AMGEN INCAMGN | Oncology, Gene Therapy, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive | 7.5 | $233.78B | Commercial | Nasdaq |
| Novo Nordisk A/SNVO | Oncology, Rare Disease, Neurology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive | 7.8 | $201.64B | Commercial | NYSE |
| ABBOTT LABORATORIESABT | Oncology, Rare Disease, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Gastroenterology, Endocrinology, Reproductive | 7.63/6 | $195.90B | Commercial | NYSE |
| GILEAD SCIENCES, INC.GILD | Oncology, Immunology, Infectious Disease, Metabolic, Respiratory, Dermatology, Gastroenterology | 6.6 | $180.64B | Commercial | Nasdaq |
| PFIZER INCPFE | Oncology, Rare Disease, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology | 8.1 | $159.36B | Commercial | NYSE |
| VERTEX PHARMACEUTICALS INC / MAVRTX | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Metabolic, Respiratory, Pain, Hematology, Nephrology, Reproductive | 8.2 | $137.21B | Commercial | Nasdaq |
| BRISTOL MYERS SQUIBB COBMY | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Psychiatry | 8.2 | $136.00B | Commercial | NYSE |
| SanofiSNY | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive | 8.8 | $109.86B | Commercial | Nasdaq |
| GSK plc American Depositary Shares (Each representing two Ordinary Shares)GSK | Oncology, Gastroenterology | 4.53/6 | $101.78B | Phase 3 | NYSE |
| REGENERON PHARMACEUTICALS, INC.REGN | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Dermatology, Hematology, Nephrology, Gastroenterology | 7.5 | $81.77B | Commercial | Nasdaq |
| ARGENX SEARGX | Oncology, Rare Disease, Neurology, Immunology, Ophthalmology, Pain, Dermatology, Hematology, Nephrology, Endocrinology | 8.0 | $64.01B | Commercial | Nasdaq |
| Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)TAK | Oncology, Rare Disease, Neurology, Immunology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Gastroenterology, Endocrinology, Reproductive, Psychiatry | 5.63/6 | $57.58B | Commercial | NYSE |
| Moderna, Inc.MRNA | Oncology, Neurology, Immunology, Infectious Disease, Respiratory, Dermatology | 6.3 | $55.09B | Commercial | Nasdaq |
| Cardinal Health Inc.CAH | Oncology, Musculoskeletal | 3.5 | $54.55B | Commercial | NYSE |
| REVOLUTION MEDICINES, INC.RVMD | Oncology, Gastroenterology | 6.5 | $44.69B | Commercial | Nasdaq |
| Teva Pharmaceutical Industries LimitedTEVA | Oncology, Rare Disease, Neurology, Immunology, Metabolic, Respiratory, Pain, Dermatology | 7.5 | $42.46B | Commercial | NYSE |
| BeOne Medicines Ltd.ONC | Oncology, Immunology, Dermatology, Nephrology, Musculoskeletal | 7.2 | $41.49B | Commercial | Nasdaq |
| Royalty Pharma plcRPRX | Oncology, Neurology, Immunology, Infectious Disease, Metabolic, Dermatology, Nephrology, Endocrinology | 6.6 | $35.16B | Commercial | Nasdaq |
| BIOGEN INC.BIIB | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Ophthalmology, Infectious Disease, Pain, Dermatology, Nephrology | 8.7 | $32.28B | Commercial | Nasdaq |
| Zoetis Inc.ZTS | Pharmaceutical preparations | 8.23/6 | $31.96B | No disclosed pipeline | NYSE |
| ALNYLAM PHARMACEUTICALS, INC.ALNY | Oncology, Rare Disease, Neurology, Cardiovascular, Metabolic, Dermatology, Hematology | 4.8 | $31.73B | Commercial | Nasdaq |
| BeOne Medicines Ltd.BEIGF | Oncology, Immunology, Dermatology | — | $29.60B | Commercial | OTC |
| INSMED IncINSM | Oncology, Rare Disease, Neurology, Immunology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Dermatology, Nephrology, Gastroenterology, Endocrinology | 7.2 | $25.89B | Commercial | Nasdaq |
| BioNTech SEBNTX | Oncology, Gene Therapy, Immunology, Infectious Disease, Respiratory | 8.5 | $25.64B | Commercial | Nasdaq |
| Incyte Corp.INCY | Oncology, Immunology, Infectious Disease, Metabolic, Respiratory, Dermatology, Hematology, Nephrology, Gastroenterology | 7.7 | $25.21B | Commercial | Nasdaq |
| Roivant Sciences Ltd.ROIV | Neurology, Immunology, Cardiovascular, Respiratory, Dermatology, Musculoskeletal | 6.0 | $25.07B | Phase 2 | Nasdaq |
| UNITED THERAPEUTICS CorpUTHR | Oncology, Rare Disease, Gene Therapy, Neurology, Immunology, Ophthalmology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Pain, Dermatology, Hematology, Nephrology, Musculoskeletal, Gastroenterology, Endocrinology, Reproductive, Psychiatry | 8.2 | $22.11B | Commercial | Nasdaq |
| Genmab A/SGMAB | Oncology, Immunology, Dermatology, Nephrology, Gastroenterology | 8.22/6 | $20.72B | Phase 3 | Nasdaq |
| Viatris IncVTRS | Oncology, Neurology, Immunology, Ophthalmology, Cardiovascular, Metabolic, Respiratory, Pain, Dermatology, Nephrology, Reproductive | 8.0 | $18.77B | Commercial | Nasdaq |
| Ascendis Pharma A/SASND | Oncology, Rare Disease, Dermatology, Endocrinology | 8.7 | $16.26B | Commercial | Nasdaq |
| Jazz Pharmaceuticals plcJAZZ | Oncology, Rare Disease, Neurology, Metabolic, Gastroenterology, Psychiatry | 7.9 | $15.87B | Commercial | Nasdaq |
| NEUROCRINE BIOSCIENCES INCNBIX | Oncology, Rare Disease, Neurology, Dermatology, Nephrology, Endocrinology, Psychiatry | 7.3 | $15.66B | Commercial | Nasdaq |
| BridgeBio Pharma, Inc.BBIO | Oncology, Rare Disease, Cardiovascular | 6.0 | $14.97B | Commercial | Nasdaq |
| Baxter International Inc.BAX | Oncology, Reproductive | 8.5 | $13.51B | Commercial | NYSE |
| EXELIXIS, INC.EXEL | Oncology, Immunology, Dermatology, Nephrology, Endocrinology | 6.6 | $13.49B | Commercial | Nasdaq |
| BIOMARIN PHARMACEUTICAL INCBMRN | Oncology, Rare Disease, Gene Therapy, Immunology, Dermatology, Hematology, Endocrinology | 8.1 | $12.48B | Commercial | Nasdaq |
| MADRIGAL PHARMACEUTICALS, INC.MDGL | Cardiovascular, Infectious Disease, Metabolic, Nephrology, Gastroenterology | 6.8 | $12.33B | Commercial | Nasdaq |
| CORCEPT THERAPEUTICS INCCORT | Oncology, Neurology, Cardiovascular, Infectious Disease, Metabolic, Nephrology, Gastroenterology, Endocrinology | 5.8 | $12.31B | Commercial | Nasdaq |
| Elanco Animal Health IncELAN | Immunology, Dermatology | 9.43/6 | $12.05B | Commercial | NYSE |
| ARROWHEAD PHARMACEUTICALS, INC.ARWR | Oncology, Rare Disease, Neurology, Immunology, Cardiovascular, Infectious Disease, Metabolic, Respiratory, Nephrology, Gastroenterology | 6.4 | $11.96B | Commercial | Nasdaq |
| HALOZYME THERAPEUTICS, INC.HALO | Endocrinology | 5.6 | $11.96B | Commercial | Nasdaq |
| BIO-TECHNE CorpTECH | Oncology, Neurology, Immunology, Dermatology | 7.93/6 | $11.35B | Phase 3 | Nasdaq |